Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours

NCT05114668 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: EVT801

Sponsor

Kazia Therapeutics Limited